CN209378230U - Physiotherapy device for department of respiration - Google Patents
Physiotherapy device for department of respiration Download PDFInfo
- Publication number
- CN209378230U CN209378230U CN201820198936.3U CN201820198936U CN209378230U CN 209378230 U CN209378230 U CN 209378230U CN 201820198936 U CN201820198936 U CN 201820198936U CN 209378230 U CN209378230 U CN 209378230U
- Authority
- CN
- China
- Prior art keywords
- medicament
- chamber
- contact layer
- nose
- powder medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000554 physical therapy Methods 0.000 title claims abstract description 12
- 230000029058 respiratory gaseous exchange Effects 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 61
- 239000000843 powder Substances 0.000 claims abstract description 33
- 239000010410 layer Substances 0.000 claims description 36
- 239000002344 surface layer Substances 0.000 claims description 15
- 208000023504 respiratory system disease Diseases 0.000 claims description 12
- 238000009423 ventilation Methods 0.000 claims description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 5
- 229910001882 dioxygen Inorganic materials 0.000 claims description 5
- 239000012790 adhesive layer Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 230000001815 facial effect Effects 0.000 claims description 3
- 210000002345 respiratory system Anatomy 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 210000001331 nose Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 11
- 239000000243 solution Substances 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- PZSXCNWLLFEOPM-UHFFFAOYSA-N [F].C(CC)(=O)O Chemical compound [F].C(CC)(=O)O PZSXCNWLLFEOPM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 238000002664 inhalation therapy Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960005018 salmeterol xinafoate Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model relates to a department of respiration physiotherapy device belongs to medical equipment technical field, including the surface course, intermediate level and contact layer have set gradually from far away to near according to the skin of face apart from on the surface course, be provided with nasal part ventilative mouth on the surface course, be provided with nasal part ventilative net and a plurality of powder medicament respectively according to the corresponding position with nasal part and mouth on the intermediate level and hold the chamber, be provided with the baffle of separating nasal part ventilative net and powder medicament and holding the chamber on the contact layer, baffle and powder medicament hold and enclose synthetic medicament between the chamber and disperse the chamber, the contact layer below is provided with the intake pipe that disperses the chamber intercommunication with the medicament. According to the technical scheme, the powder dispersing cavity can hold a part of the powder medicament in the cavity after the air flow is sprayed into the air inlet pipe, the powder medicament enters the respiratory system through the mouth of a user, the expiration channel of the cavity and the nose is separated from the medicament dispersing cavity due to the existence of the baffle, irritation of the powder medicament to the nasal mucosa is avoided, and the beneficial effect is remarkable.
Description
Technical field
The utility model relates to a kind of division of respiratory disease physical therapy devices, belong to technical field of medical equipment.
Background technique
In the therapy field of division of respiratory disease disease, inhalation therapy is a kind of important administration mode, in treatment such as asthma
Biggish superiority has been had shown that in a variety of administration routes of this kind of respiratory disease.Its advantage mainly has following
Aspect.
First, the drug of sucking directly acts on air flue, without blood circulation, can reach diseased region rapidly,
Make drug need not by it is oral when bioavilability and liver first-pass effect influenced, 3~5 minutes i.e. after the sucking of certain suppressing panting calming medicines
Antiasthmatic effect can be played, thus it is rapid-action, it can be with Rapid Expansion bronchus and confrontation airway inflammation；
Second, drug dose needed for Sucked medicine is small, and sucking dose is only the 1/20~1/10 of oral dose, therefore drug draws
The Systemic reaction risen, which is considerably less than, to be administered orally, without gastrointestinal tract, not by the effect of gastric acid and digestive ferment, no digestion
Road adverse reaction, it is harmless to liver without liver metabolism, it is few into the drug in blood, to the small toxicity of kidney；
Third after some fat-soluble medicines are inhaled into, do not enter blood by air flue mucosal absorption, acts only on part.It both can be with
Local drug concentration is improved, and the adverse reaction of the whole body generated by oral, intramuscular injection or intravenous injection medication can be mitigated,
Especially inhaled above shows huge superiority in the application for the treatment of asthma, so that glucocorticoid may be at
For the first-line drug for treating asthma.
Summary of the invention
To solve problems of the prior art, the utility model provides a kind of division of respiratory disease physical therapy device, Neng Gouli
With traditional oxygen supply device, the supply of powder medicament is carried out, it is convenient and practical.Specific technical solution is as follows:
A kind of division of respiratory disease physical therapy device, including surface layer, in the surface layer according to apart from facial skin from as far as closely successively setting
Be equipped with middle layer and contact layer, be provided with nose ventilation mouth in the surface layer, in the middle layer according to nose and mouth
Corresponding position is respectively arranged with nose gas-permeable nets and multiple powder medicament accommodating chambers, and it is saturating that separation nose is provided on the contact layer
The baffle of gas net and powder medicament accommodating chamber encloses medicament diverging between the contact layer, baffle and powder medicament accommodating chamber
Chamber, the contact layer lower section are provided with the air inlet pipe being connected to medicament diverging chamber.
As an improvement of the above technical solution, the position on the contact layer close to mouth is offered connects with medicament diverging chamber
Logical air intake passage.
As an improvement of the above technical solution, it is provided with protrusion on the contact layer, corresponds to protrusion in the middle layer
Position be provided with embeded slot, the protrusion and embeded slot are nested.
As an improvement of the above technical solution, the surface layer two sides extend outward to form head band, the band end
It is provided with adhesive layer.
As an improvement of the above technical solution, oxygen gas pipeline is offered in the air inlet pipe, in oxygen gas pipeline
Cloth set direction between the emission direction of air-flow and multiple powder medicament accommodating chambers is consistent.
As an improvement of the above technical solution, the nose gas-permeable nets and nose ventilation mouth correspond to each other.
Above-mentioned technical proposal Chinese medicine dissipates chamber can be after air inlet pipe sprays into air-flow, by the powder in powder medicament accommodating chamber
Body medicament rolls a part, and is entered in respiratory system by user's mouth, and the presence of baffle, by medicament diverging chamber with
The exhalation passages of nose are kept apart, and stimulation of the powder medicament to nasal mucous membranes is avoided, and beneficial effect is significant.
Detailed description of the invention
Fig. 1 is a kind of structural schematic diagram of division of respiratory disease physical therapy device of the utility model；
Fig. 2 is a kind of schematic diagram of internal structure of division of respiratory disease physical therapy device of the utility model.
Specific embodiment
As shown in Figure 1 and Figure 2, the utility model provides a kind of division of respiratory disease physical therapy device, including surface layer 10, in surface layer 10
, from as far as closely middle layer 20 and contact layer 30 is disposed with, nose ventilation mouth is provided in surface layer 10 according to apart from facial skin
11, nose gas-permeable nets 22 are respectively arranged with according to the corresponding position with nose and mouth in middle layer 20 and multiple powder medicament are held
Receive chamber 21, wherein nose gas-permeable nets 22 and nose ventilation mouth 11 correspond to each other, and are provided on contact layer 30 and separate nose gas-permeable nets
22 and powder medicament accommodating chamber 21 baffle 33, enclose medicament between contact layer 30, baffle 33 and powder medicament accommodating chamber 21
Chamber 50 is dissipated, the air inlet pipe 40 being connected to medicament diverging chamber 50 is provided with below contact layer 30.
In above scheme, powder medicament accommodating chamber 21 can accommodate such as SALMETEROL XINAFOATE and propionic acid fluorine replaces or sugar
Corticoid drug, can also be using other kinds of asthma disease therapeutic agent in the prior art.Connect below air inlet pipe 40
It is connected to oxygen supply device, chamber 50 is dissipated to medicament by air inlet pipe 40 and injects oxygen, when air-flow passes through, powder medicament is accommodated
Powder in chamber 21 enters directly into along with the air-breathing of user's mouth in respiratory system.In the program, division of respiratory disease physical therapy
The breathing pattern that device is proposed with mouth air-breathing when in use, nose is exhaled, since medicament diverging chamber 50 is relatively independent,
The problem of powder medicament will not enter nose, avoid powder from stimulating nasal mucous membranes, therefore do not have unsmooth breath, and user
Nose corresponds to nose gas-permeable nets 22 and nose ventilation mouth 11, thus the expiration of nose be also able to maintain it is unobstructed.
Powder medicament accommodating chamber 21 uses the form of a side opening in design, i.e. the side of direction medicament diverging chamber 50 is opened
Hole, and away from the one side closed of medicament diverging chamber 50, the number of aperture and aperture by the unit time for determining powder medicament to
Pharmaceutical quantities.
In above scheme, surface layer 10 and contact layer 30 can be fixed by way of suture connection, and contact layer 30 is close to face
Portion's skin, the position on contact layer 30 close to mouth offer the air intake passage 31 being connected to medicament diverging chamber 50, pass through air-breathing
Channel 31 may insure that user's air-breathing is unobstructed.
Middle layer 20 is inserted from above between surface layer 10 and contact layer 30, and protrusion 32 is provided on contact layer 30, intermediate
The position for corresponding to protrusion 32 on layer 20 is provided with embeded slot 23, after middle layer 20 is inserted between surface layer 10 and contact layer 30,
The protrusion 32 of contact layer 30 and the embeded slot 23 of middle layer 20 are nested, to realize the fixation of middle layer 20.
In above scheme, 10 two sides of surface layer extend outward to form head band 12, and 12 end of band is provided with adhesive layer 13,
The band 12 of two sides can be fitted to head by user, and is fixed using band 12 of the adhesive layer 13 to two sides.
In above scheme, oxygen gas pipeline 41, the ejection of 41 interior air-flow of oxygen gas pipeline are offered in air inlet pipe 40
Cloth set direction between direction and multiple powder medicament accommodating chambers 21 is consistent, why so designs, and is that air-flow is straight in order to prevent
It is mapped to powder medicament accommodating chamber 21, powder medicament is caused largely to enter in respiratory system, powder medicament is avoided excessively to generate
The problem of unsmooth breath.
The embodiments of the present invention are described in detail above, but the content is only the preferable of the utility model
Embodiment should not be considered as limiting the scope of the present invention, all to become according to equalization made by the scope of the utility model
Change and improve etc., it should still belong within the utility model covering scope.
Claims (2)
1. a kind of division of respiratory disease physical therapy device, which is characterized in that including surface layer, in the surface layer according to apart from facial skin from as far as
Closely be disposed with middle layer and contact layer, be provided with nose ventilation mouth in the surface layer, in the middle layer according to nose
Nose gas-permeable nets and multiple powder medicament accommodating chambers are respectively arranged with the corresponding position of mouth, are provided on the contact layer point
It is enclosed between the baffle of nose gas-permeable nets and powder medicament accommodating chamber, the contact layer, baffle and powder medicament accommodating chamber
Medicament dissipates chamber, and the air inlet pipe being connected to medicament diverging chamber is provided with below the contact layer；Close to mouth on the contact layer
Position offer and the air intake passage that is connected to of medicament diverging chamber；It is provided with protrusion on the contact layer, it is right in the middle layer
The position of protrusion should be provided with embeded slot, the protrusion and embeded slot are nested；10 two sides of surface layer extend outwardly shape
At head band, the band end is provided with adhesive layer；Oxygen gas pipeline, oxygen appendix are offered in the air inlet pipe
Cloth set direction between the emission direction of road interior air-flow and multiple powder medicament accommodating chambers is consistent.
2. a kind of division of respiratory disease physical therapy device as described in claim 1, which is characterized in that the nose gas-permeable nets and nose are ventilative
Mouth corresponds to each other.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820198936.3U CN209378230U (en) | 2018-02-05 | 2018-02-05 | Physiotherapy device for department of respiration |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820198936.3U CN209378230U (en) | 2018-02-05 | 2018-02-05 | Physiotherapy device for department of respiration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209378230U true CN209378230U (en) | 2019-09-13 |
Family
ID=67868258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201820198936.3U Expired - Fee Related CN209378230U (en) | 2018-02-05 | 2018-02-05 | Physiotherapy device for department of respiration |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209378230U (en) |
-
2018
- 2018-02-05 CN CN201820198936.3U patent/CN209378230U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200261671A1 (en) | Gas therapy system | |
| Dhand | Aerosol therapy in patients receiving noninvasive positive pressure ventilation | |
| US10695517B2 (en) | Nasal breathing apparatus and method with multifunction | |
| JP6153725B2 (en) | Ventilation assistance system and ventilator including an unsealed ventilation interface with intake ports and / or pressure features | |
| JP5507539B2 (en) | Ventilation circuit adapter and proximal aerosol delivery system | |
| US6019100A (en) | Ventilator device | |
| KR20230136692A (en) | oxygen mask | |
| AU2002342108A1 (en) | Nasal cannula | |
| US11707593B2 (en) | Sedation device | |
| Harb et al. | Update efficacy of aerosol therapy with noninvasive ventilator approach (non-invasive ventilation and nasal high flow) | |
| CN209378230U (en) | Physiotherapy device for department of respiration | |
| KR101333195B1 (en) | Nasal interface for constant nasopharyngeal pressure during high-flow humidified oxygen therapy | |
| JP3230416U (en) | Medical and health eye masks | |
| US20190076612A1 (en) | Nasal inhaler for use with nebulizer system | |
| CN115282411A (en) | Delivery system for delivering drugs into the brain using the nasal olfactory region and method of use thereof | |
| CN113318313A (en) | Inhalation anesthesia induction device for children | |
| CN207768878U (en) | It is a kind of to treat pneumoconiosis oxygenation atomization suction apparatus | |
| CN206138548U (en) | Medical heat and humidity exchange device | |
| CN220588704U (en) | Aerosol auxiliary inhalation device | |
| CN212282480U (en) | Oxygen mask suitable for postoperative use of nasal cavity operation | |
| CN211512967U (en) | A aerosol inhalation device for child's internal medicine | |
| CN114768012A (en) | Synchronous nasal cavity autonomous quantitative medicine delivery device with expiration | |
| RU127633U1 (en) | DEVICE FOR INHALATION ADMINISTRATION OF MEDICINES UNDER NON-INVASIVE LUNG VENTILATION | |
| RU126941U1 (en) | DEVICE FOR DELIVERY OF MEDICINES WITH NON-INVASIVE LUNG VENTILATION | |
| CN115300726A (en) | Special nasal delivery system and application method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190913 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |